New Delhi/IBNS: The Union health ministry on Sunday said that the online appointments, already made for the second dose of the Covishield vaccine, will not be cancelled on Co-WIN platform.
India will complete administering 51.6 crore vaccine doses by July-end
New Delhi/IBNS: India will complete administering 51.6 crore Covid-19 vaccine doses by the end of July, Union Health Minister Harsh Vardhan said on Saturday.
Covid-19: Misuse of steroids responsible for growing mucormycosis cases, says AIIMS chief
New Delhi/IBNS: AIIMS director Dr. Randeep Guleria on Saturday said misuse of steroids is the main cause behind the cases of mucormycosis infection commonly known as the 'Black Fungus' as he warned against the rise in the rare infection.
India reports 3.26 lakh Covid-19 cases, 3,890 deaths in 24 hours
New Delhi/IBNS: Reporting the lowest daily cases in 18 days, India, which is massively hit by the second wave of Novel Coronavirus, added 3.26 lakh new infections on Saturday.
Govt panel recommends vaccination for Covid patients after 6 months of recovery
New Delhi/IBNS: People infected with Covid-19 should go for vaccination six months after recovery, according to the National Technical Advisory Group on Immunisation (NTAGI) that held a meeting recently, said media reports.
New Delhi/IBNS: The Central government has started working with the pharma companies producing amphotericin B to ramp up the production of anti-fungal medicine used in the treatment of mucormycosis, the “black fungus" infection being reported in some covid-19 patients across India.
Madhya Pradesh govt worried after 50 patients diagnosed with Black Fungal Disease
Bhopal/IBNS: Covid patients being infected with mucormycosis or "black fungal disease" have been increasing and fifty more infected patients in Madhya Pradesh have been diagnosed with the rare infection caused by a group of moulds called "mucormycetes" and affect people with weak immune systems.
India's Covid cases have peaked, reflects Cambridge tracker: Report
New Delhi/IBNS: The coronavirus infections in India have reached the peak according to a tracker developed by the researchers at Cambridge Judge Business School and the National Institute of Economic and Social Research, said a Bloomberg report.
Why more young are getting affected by second wave of Covid-19? ICMR chief has the answer
New Delhi/IBNS: The second wave of Covid-19 is affecting the young people slightly more as they might have started going out and also because of some strains of SARS-COV-2 active in the country, Indian Council of Medical Research (ICMR) chief said on Tuesday.
After 44 die in Aligharh Muslim University, vice-chancellor suspects 'lethal' strain
Aligarh/IBNS: After 44 Aligharh Muslim University staff, 19 professors and 25 non-teaching staff died of Covid-19, the varsity's vice-chancellor has written to the ICMR (Indian Council for Medical Research) asking for genome sequencing of what he suspects a "lethal" variant of the novel coronavirus.
India records 4.03 lakh fresh Covid cases, 4,092 deaths in last 24 hours
New Delhi/IBNS: India recorded 4,03,738 fresh Covid cases and 4,092 deaths in the last 24 hours, the Union Health Ministry said on Sunday.
DCGI approves DRDO's anti-COVID oral drug '2-DG' for emergency use
New Delhi/IBNS: The Drug Controller General of India (DCGI) has approved the emergency use of DRDO's anti-COVID-19 therapeutic oral drug 2-deoxy-D-glucose (2-DG) as an adjunct therapy in moderation to severe COVID-19 patients.
CT scan effective tool to detect, determine severity of Covid-19 cases: DAK
Srinagar/UNI: Doctors Association Kashmir (DAK) on Saturday said chest CT scan is an effective tool to detect and determine the severity of Covid-19 cases.
Johnson & Johnson to start clinical trial for it Covid vaccine at Kolkata's Peerless Hospital
Kolkata/UNI: Peerless Hospital has been selected as the only trial venue in the East for Johnson & Johnson for their single dose vaccine which is currently being used under emergency authorization in USA.
China's Sinopharm Covid-19 vaccine gets WHO's nod for emergency use
Geneva/IBNS: The World Health Organisation (WHO) on Friday gave emergency use approval for a coronavirus vaccine made by China's state-owned drug manufacturer Sinopharm, said a Reuters report.